Richemont keeps recapitalising houses that analysts have urged it to sell, and the explanation is not turnaround logic. Delvaux alone has taken two cash injections in four years, most recently a €100.6 million debt-to-equity conversion in April 2026, while the wider Other segment has run an operating loss in every recent reporting period. Read against the annuals, the pattern is not triage. It is carry — the recurring cost of holding a portfolio no buyer will pay book value for.

The size of the Other segment’s losses matters less than the cadence. FY25 closed at a -3.7% operating margin, and H1 FY26 followed with another €33 million of red ink concentrated specifically at the Fashion & Accessories Maisons. Those numbers are not large against the Group’s jewellery cash flow. They are persistent. They behave like rent.

Kering offered Johann Rupert a cash-and-shares merger in January 2021 and was refused without a board referral. When a strategic peer with synergistic interest in the Soft Luxury houses tries to put a value on them, the price comes back too low to put to shareholders. A standalone disposal of Chloé, Delvaux, Dunhill or Montblanc would face the same arithmetic. Buyers price what the operating account shows; the catalogue collection does not enter the bid. Selling at that price would force the impairment Richemont has so far avoided by recapitalising instead. The recap costs less, on the books, than honesty about carrying value.

Carry as a financial concept describes the recurring cost of maintaining a position you cannot or will not close. In private equity, it is the management fee on a fund whose IRR has gone underwater. In real estate, it is property tax and maintenance on a building no buyer will meet the asking price for. In Richemont’s accounts, it is the Other segment’s loss line plus the periodic injections into Delvaux, Dunhill and YNAP. These payments keep the assets reported at favourable carrying values, rather than crystallising the markdown that a sale would force.

The YNAP transfer to Mytheresa, closed in April 2025, is the same logic at higher amplitude. Richemont did not sell its e-commerce arm for cash; it transferred the asset with a €555 million cash endowment and no debt attached, taking a 33% Mytheresa stake and adding a credit facility, then booked the carrying value down in stages totalling more than €4 billion. The transaction is structurally a pay-to-leave: the seller wrote a cheque to escape the position rather than collect one. What that priced was the cost of holding a balance-sheet item the public market refused to value at par. The Soft Luxury Maisons sit in the same logic at lower amplitude. They are small enough to live with on the books, hard enough to sell that the recap beats the impairment, and creative-led in ways that resist the standardised cost-out programme buyers run before bidding.

Carry, in this sense, is the price of postponing price discovery.

The bull case is that the carry is short and almost over. Alaïa has grown at a double-digit rate across several reporting periods under Pieter Mulier, with handbag traction supplying what Richemont has historically lacked: a Soft Luxury house with both creative momentum and an entry-price accessory franchise. Chloé returned to growth under its current creative director; Peter Millar is the quiet earner. If Fashion & Accessories reaches breakeven inside two years, which the FY24 result already gestured at, the recapitalisations of 2022 and 2026 will read as patient capital rather than carry — sunk cost translated into earned multiples on exit. The case has the shape of an investment thesis Richemont has been promising for fifteen years.

That case requires three conditions to hold together. Alaïa has to scale beyond a creative-director hit into a bag-and-leather franchise that survives the eventual successor. Chloé’s recovery has to outlive the next directorial cycle, which historically it has not. Delvaux, Dunhill and Montblanc have to either fold quietly or find buyers at carrying value. The first condition is plausible on the creative evidence; the second has been a serial promise since the 2010s; the third assumes a buyer pool that two decades of failed sale rumours have not produced. If any of the three slips, Richemont is back at the cheque book.

Richemont can afford the carry several times over. The Group threw off €4.4 billion in operating cash flow in FY25, a figure that turns the Other segment’s losses into a line item rather than a crisis. What the recapitalisations register, then, is a holding decision: the Group is paying rent on optionality, in the hope that another Alaïa eventually closes the gap on its own. That is a defensible position while the jewellery houses are this profitable, and a less interesting one than the language of “strategic investment” in the annuals would suggest. The price of that choice shows up in every interim report. The only question worth asking the chairman is whether the rent is worth the building.